2022 Hospital Medicine Summit Live CE/CME Virtual Conference

2022 Hospital Medicine Summit

Saturday, December 3, 2022
8:00 AM – 1:30 PM EST

Complimentary Live Virtual CE/CME Conference!

Earn up to 5.0 AMA, MOC, ANCC, and ACPE credits!

PROVIDER STATEMENT

       

This CME activity for ACCME credit is provided by Integrity Continuing Education, Inc.

This CE activity for ANCC and ACPE credit is jointly provided by Global Education Group and Integrity Continuing Education, Inc.

DISCLOSURE OF COMMERCIAL SUPPORT

This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals, Daiichi Sankyo, Inc., GlaxoSmithKline, and Salix Pharmaceuticals.

EDUCATIONAL PARTNERS

     

Monmouth-Ocean Medical Society
Philadelphia County Medical Society

PROGRAM OVERVIEW

Since 2015, the Hospital Medicine Summit (HMS), a multidisciplinary educational event, has been providing an exceptional educational experience that is inclusive of clinicians who manage patients in the acute setting and those who have transitioned to the chronic-care setting. Serving hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses, HMS fulfills a critical need to address significant changes in the healthcare system and the increased demand on these clinicians so they can provide optimal care to patients both in the hospital or acute care setting and when they are discharged into the community healthcare system.

TARGET AUDIENCE

This educational activity has been designed to meet the needs of physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists who practice in hospital, internal medicine, and chronic-care settings.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Keynote: Collaborative Care Between Hospital-based Clinicians and Community Specialists

  • Learning objectives to come

Session 1 – Taking the Kidneys to Heart: Managing CKD-Related Anemia With Emerging HIF-PHIs

  • Clarify the disease burden imposed by untreated or undertreated anemia in patients with chronic kidney disease (CKD), including in racially diverse populations
  • Correlate the pathophysiology of anemia in CKD with viable therapeutic targets
  • Identify appropriate candidates for emerging CKD-related anemia treatments among patients on or not on dialysis based on efficacy and safety data from recent clinical trials

Session 2The Role of the Hospitalist: A Focus on Oncology Treatment Adverse Events

  • Review the associated grade <3 treatment-related adverse events (trAE) with new and novel anticancer agents
  • Identify patients presenting with serious trAEs and devise an appropriate management plan

Session 3 Fireside Chat* Faculty Panel Discussion

  • Correlate the pathophysiology of anemia in CKD with viable therapeutic targets
  • Identify patients presenting with cancer trAEs and devise an appropriate management plan
  • Discuss how to implement a plan of care for patients hospitalized with hepatic encephalopathy (HE) that is consistent with updated evidence-based recommendations

*Learning objectives subject to change for this session

Session 4 – Evidence-based Care and Therapeutic Updates to Reduce the Risk for Rapid Progression and Recurrence of Hepatic Encephalopathy

  • Discuss how to implement a plan of care for patients hospitalized with HE that is consistent with updated evidence-based recommendations
  • Describe the efficacy and safety of therapies for treatment of acute episodes of overt HE and prevention of their recurrence
  • Identify crucial components of a transitional care plan to prevent future hospitalizations among patients with HE

KEYNOTE SPEAKER/PROGRAM MODERATOR

Alpesh Amin, MD, MBA, FACC, MACP, SFHM
Thomas & Mary Cesario Chair of Medicine
Professor of Medicine, Business, Public Health,
Nursing Science, and Biomedical Engineering
Executive Director, Hospitalist Program
Medical Director, Anticoagulation Services
University of California, Irvine
Irvine, California

FACULTY PRESENTERS

Benjamin L. Kitchens, MD
Medical Oncology
Texas Oncology/Baylor University Medical Center
Dallas, Texas

Biff F. Palmer, MD, FACP, FASN
Professor of Internal Medicine
University of Texas Southwestern Medical Center
Dallas, Texas

Robert Rahimi, MD
Transplant Hepatology
Baylor University Medical Center
Associate Professor
Department of Medicine
Texas A&M Health Science Center
College of Medicine
Liver Consultants of Texas
Baylor Charles A. Sammons Cancer Center
Dallas, Texas

ACCREDITATION

Physician Continuing Education

Accreditation Statement
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Integrity Continuing Education, Inc. designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 5.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation
Global Education Group designates this continuing education activity for 5.0 contact hours (0.5 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Numbers – 0530-9999-22-234-L01-P, 0530-9999-22-235-L01-P, 0530-9999-22-236-L01-P, 0530-9999-22-237-L01-P, 0530-9999-22-238-L01-P.)

This is a knowledge-based activity.

Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete each session’s pretest, attend each session, and complete the posttest and evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form. For pharmacist/ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity. Credit cannot be issued after 60 days.

FEE INFORMATION

There is no fee for attending this virtual conference; however, space is limited. Early preregistration is recommended to reserve your space.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global Education Group at (303) 395-1782 or cme@globaleducationgroup.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. and Global Education Group adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integrity Continuing Education, Inc. and Global Education Group are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by Integrity Continuing Education, Inc. and Global Education Group in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integrity Continuing Education, Inc. and Global Education Group to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty will disclose all relevant financial relationships with ineligible companies prior to their presentation at the 2022 HMS.

The planners and managers at Integrity Continuing Education, Inc. and Global Education Group have no relevant financial relationships to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Global Education Group do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Agenda

On the day of the event, you may access the broadcast by visiting the following link:

https://event.arraylive.com/app/login/a7d25db2-c60c-4143-b4a0-8e41d9e8df93

Agenda*

All times are stated in EST.

8:00 AM – 8:15 AM Opening Remarks
8:15 AM – 9:00 AM Keynote Presentation: Collaborative Care Between Hospital-based Clinicians and Community Specialists
9:00 AM – 10:15 AM Taking the Kidneys to Heart: Managing CKD-Related Anemia With Emerging HIF-PHIs
10:15 AM – 10:30 AM Break
10:30 AM – 11:45 PM The Role of the Hospitalist: A Focus on Oncology Treatment Adverse Events
11:45 PM – 12:15 PM Fireside Chat Faculty Panel Discussion
12:15 PM – 1:30 PM Evidence-based Care and Therapeutic Updates to Reduce the Risk for Rapid Progression and Recurrence of Hepatic Encephalopathy
1:30 PM Adjournment

*Agenda is subject to change